The Cooperative Human Tissue Network of the National Cancer Institute: Supporting Cancer Research for 35 Years

Overview

Journal Mol Cancer Ther

Date 2023 Jul 31

PMID 37523711

Authors

Shannon J McCall

Irina A Lubensky

Christopher A Moskaluk

Anil Parwani

Kiley Radin

Nilsa C Ramirez

Zachery Von Menchhofen

Mary K Washington

Virginia A LiVolsi

Affiliations

Soon will be listed here.

Abstract

The Cooperative Human Tissue Network was created by the NCI in 1987 to support a coordinated national effort to collect and distribute high quality, pathologist-validated human tissues for cancer research. Since then, the network has expanded to provide different types of tissue samples, blood and body fluid samples, immunohistologic and molecular sample preparations, tissue microarrays, and clinical datasets inclusive of biomarkers and molecular testing. From inception through the end of 2021, the network has distributed 1,375,041 biospecimens. It served 889 active investigators in 2021. The network has also taken steps to begin to optimize the representation of diverse communities among the distributed biospecimens. In this article, the authors review the 35-year history of this network, describe changes to the program over the last 15 years, and provide operational and scientific highlights from each of the divisions. Readers will learn how to engage with the network and about the continued evolution of the program for the future.

References

Nahas S, Nahas C, Sparapan Marques C, Ribeiro Jr U, Cotti G, Imperiale A . Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer. Dis Colon Rectum. 2016; 59(4):255-63. DOI: 10.1097/DCR.0000000000000558. View

Frampton G, Fichtenholtz A, Otto G, Wang K, Downing S, He J . Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol. 2013; 31(11):1023-31. PMC: 5710001. DOI: 10.1038/nbt.2696. View

Allocca C, Snapes E, Albert M, Bledsoe M, Castelhano M, De Wilde M . Biobanking in the COVID-19 Era and Beyond: Part 2. A Set of Tool Implementation Case Studies. Biopreserv Biobank. 2020; 18(6):547-560. PMC: 7757526. DOI: 10.1089/bio.2020.0083. View

Grizzle W, Aamodt R, Clausen K, LiVolsi V, Pretlow T, Qualman S . Providing human tissues for research: how to establish a program. Arch Pathol Lab Med. 1998; 122(12):1065-76. View

Peng J, Wey J, Chalikonda S, Allende D, Walsh R, Morris-Stiff G . Pathologic tumor response to neoadjuvant therapy in borderline resectable pancreatic cancer. Hepatobiliary Pancreat Dis Int. 2019; 18(4):373-378. DOI: 10.1016/j.hbpd.2019.05.007. View

Vaught J, Rogers J, Myers K, Lim M, Lockhart N, Moore H . An NCI perspective on creating sustainable biospecimen resources. J Natl Cancer Inst Monogr. 2011; 2011(42):1-7. DOI: 10.1093/jncimonographs/lgr006. View

Grizzle W, Bledsoe M, Al Diffalha S, Otali D, Sexton K . The Utilization of Biospecimens: Impact of the Choice of Biobanking Model. Biopreserv Biobank. 2019; 17(3):230-242. PMC: 7061300. DOI: 10.1089/bio.2019.0008. View

Burtin F, Matschos S, Prall F, Mullins C, Krohn M, Linnebacher M . Creation and Maintenance of a Living Biobank - How We Do It. J Vis Exp. 2021; (170). DOI: 10.3791/62065. View

Livolsi V, Clausen K, Grizzle W, Newton W, Pretlow 2nd T, Aamodt R . The Cooperative Human Tissue Network. An update. Cancer. 1993; 71(4):1391-4. DOI: 10.1002/1097-0142(19930215)71:4<1391::aid-cncr2820710434>3.0.co;2-x. View

10.

Allocca C, Bledsoe M, Albert M, Anisimov S, Bravo E, Castelhano M . Biobanking in the COVID-19 Era and Beyond: Part 1. How Early Experiences Can Translate into Actionable Wisdom. Biopreserv Biobank. 2020; 18(6):533-546. DOI: 10.1089/bio.2020.0082. View

11.

Shaker N, Sardana R, Hamasaki S, Nohle D, Ayers L, Parwani A . Accuracy of whole slide image based image analysis is adversely affected by preanalytical factors such as stained tissue slide and paraffin block age. J Pathol Inform. 2022; 13:100121. PMC: 9577058. DOI: 10.1016/j.jpi.2022.100121. View

12.

Clausen K, Grizzle W, LiVolsi V, NEWTON Jr W, Aamodt R . Special communication. The Cooperative Human Tissue Network. Cancer. 1989; 63(7):1452-5. DOI: 10.1002/1097-0142(19890401)63:7<1452::aid-cncr2820630736>3.0.co;2-#. View

13.

Loupakis F, Sharma S, Derouazi M, Murgioni S, Biason P, Rizzato M . Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases. JCO Precis Oncol. 2021; 5. PMC: 8315303. DOI: 10.1200/PO.21.00101. View

14.

Movva S, Wen W, Chen W, Millis S, Gatalica Z, Reddy S . Multi-platform profiling of over 2000 sarcomas: identification of biomarkers and novel therapeutic targets. Oncotarget. 2015; 6(14):12234-47. PMC: 4494935. DOI: 10.18632/oncotarget.3498. View

15.

Grizzle W, Gunter E, Sexton K, Bell W . Quality management of biorepositories. Biopreserv Biobank. 2015; 13(3):183-94. PMC: 4559203. DOI: 10.1089/bio.2014.0105. View

16.

Guillaumet-Adkins A, Rodriguez-Esteban G, Mereu E, Mendez-Lago M, Jaitin D, Villanueva A . Single-cell transcriptome conservation in cryopreserved cells and tissues. Genome Biol. 2017; 18(1):45. PMC: 5333448. DOI: 10.1186/s13059-017-1171-9. View

17.

Jewell S, Srinivasan M, McCart L, Williams N, Grizzle W, LiVolsi V . Analysis of the molecular quality of human tissues: an experience from the Cooperative Human Tissue Network. Am J Clin Pathol. 2002; 118(5):733-41. DOI: 10.1309/VPQL-RT21-X7YH-XDXK. View

18.

Bertucci F, Ng C, Patsouris A, Droin N, Piscuoglio S, Carbuccia N . Genomic characterization of metastatic breast cancers. Nature. 2019; 569(7757):560-564. DOI: 10.1038/s41586-019-1056-z. View

19.

Eckhoff A, Fletcher A, Landa K, Iyer M, Nussbaum D, Shi C . Multidimensional Immunophenotyping of Intraductal Papillary Mucinous Neoplasms Reveals Novel T Cell and Macrophage Signature. Ann Surg Oncol. 2022; 29(12):7781-7788. PMC: 9949893. DOI: 10.1245/s10434-022-12157-0. View

20.

Gerlinger M, Rowan A, Horswell S, Math M, Larkin J, Endesfelder D . Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012; 366(10):883-892. PMC: 4878653. DOI: 10.1056/NEJMoa1113205. View